Cardinal Capital Management - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 30 filers reported holding TENAX THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cardinal Capital Management ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$5,000
+66.7%
10,0000.0%0.00%
+100.0%
Q3 2017$3,000
-57.1%
10,0000.0%0.00%
-50.0%
Q2 2017$7,000
+16.7%
10,0000.0%0.00%0.0%
Q1 2017$6,000
-70.0%
10,0000.0%0.00%
-75.0%
Q4 2016$20,000
-13.0%
10,0000.0%0.01%
-11.1%
Q3 2016$23,00010,0000.01%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,108,593$3,326,0001.32%
RA Capital Management 2,670,300$8,011,0001.15%
Opaleye Management Inc. 635,000$1,905,0000.94%
Broadfin Capital, LLC 1,968,631$5,906,0000.33%
SABBY MANAGEMENT, LLC 2,604,660$7,892,0000.32%
DAFNA Capital Management LLC 81,509$245,0000.24%
ARMISTICE CAPITAL, LLC 88,739$266,0000.09%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$52,0000.04%
Verition Fund Management LLC 25,640$78,0000.02%
COMMERZBANK AKTIENGESELLSCHAFT /FI 738,592$2,216,0000.02%
View complete list of TENAX THERAPEUTICS INC shareholders